Atorvastastin and HIV associated immune activatio

Not Applicable

• Conditions: HIV/AIDS; Nutritional, Metabolic, Endocrine

• Registration Number: PACTR201301000445375
• Lead Sponsor: Damalie Nakanjako

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-10-26
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Age 18years and above
HAART for at least 4 years
Sustained viral suppression
CD4 increase below 300 (from the baseline)

Exclusion Criteria

History of opportunistic infection in the previous 6 months
Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified